/ /

  • linkedin
  • Increase Font
  • Sharebar

    Justine Smith begins term as new ARVO president

    Rockville, MD—Justine Smith, FRANZCO, PhD, FARVO, of Flinders University, Adelaide, South Australia, is the new president of the Association for Research in Vision and Ophthalmology (ARVO).

    Dr. Smith succeeds Peng T. Khaw, MD, PhD, FARVO, of the Moorfields Eye Hospital and UCL Institute of Ophthalmology in England, whose 1-year term ended following the ARVO annual meeting earlier this month.

    “It’s an honor to serve as president of this international group of leading and emerging leaders in eye and vision research,” Dr. Smith said. “I look forward to collaborating with our members in the coming year as we explore our efforts advancing areas as diverse as neuroscience, tissue imaging, and preventative medicine under the ARVO 2014 theme, ‘Leading Eye and Vision Research.’”

    ARVO also announced its new vice presidents. They are John S. Penn, PhD, FARVO, of Vanderbilt University and David R. Williams, PhD, FARVO, of the University of Rochester.

    William F. Mieler, MD, of the University of Illinois-Chicago is president-elect amd will serve the 2014-2015 term. Carol B. Toris, PhD, FARVO, of the University of Rochester is the vice president-elect for that term.

    In addition, ARVO members elected two new trustees to its board. Serving a 5-year term are Sarah E. Coupland, MBBS, PhD, of the University of Liverpool, representing the Anatomy Pathology Section, and Claude F. Burgoyne, MD, FARVO, of the Devers Eye Institute/Legacy Research Institute, representing the Glaucoma Section. The new trustees began their terms after the 2013 annual meeting.

    For more articles in this issue of Ophthalmology Times eReport, click here.

     

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results